Search results for "contrast agents"

showing 10 items of 10 documents

Synthesis, Stability and Relaxivity of TEEPO-Met: An Organic Radical as a Potential Tumour Targeting Contrast Agent for Magnetic Resonance Imaging

2018

Cancer is a widespread and life-threatening disease and its early-stage diagnosis is vital. One of the most effective, non-invasive tools in medical diagnostics is magnetic resonance imaging (MRI) with the aid of contrast agents. Contrast agents that are currently in clinical use contain metals, causing some restrictions in their use. Also, these contrast agents are mainly non-specific without any tissue targeting capabilities. Subsequently, the interest has notably increased in the research of organic, metal-free contrast agents. This study presents a new, stable organic radical, TEEPO-Met, where a radical moiety 2,2,6,6-tetraethylpiperidinoxide (TEEPO) is attached to an amino acid, methio…

116 Chemical sciencesPharmaceutical ScienceContrast Media01 natural sciencesAnalytical Chemistrylaw.inventionGLUCOSENuclear magnetic resonancePiperidineslawHeterocyclic CompoundsNeoplasmsDrug DiscoveryMoietymagneettitutkimusSpin labelElectron paramagnetic resonanceta116orgaaniset yhdisteetmedicine.diagnostic_testMolecular StructureChemistryPhantoms ImagingRelaxation (NMR)radicalsMagnetic Resonance Imaging3. Good healthChemistry (miscellaneous)Molecular MedicineMRIRadical010402 general chemistryvapaat radikaalitImaging phantomArticleCyclic N-OxidesvarjoainetutkimusnitroxidesmedicineAnimalsHumanscontrast agentstyppiyhdisteetPhysical and Theoretical Chemistrymethionine010405 organic chemistryOrganic ChemistryElectron Spin Resonance SpectroscopyMagnetic resonance imagingIN-VITRO3126 Surgery anesthesiology intensive care radiologynitroxides; radicals; methionine; contrast agents; MRI; NMR; EPRIn vitroNMRTRANSPORT0104 chemical sciencesREDUCTIONSPIN-LABEL1182 Biochemistry cell and molecular biologyEPRMolecules; Volume 23; Issue 5; Pages: 1034
researchProduct

Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial

2007

OBJECTIVE. The purpose of this study was to compare gadobenate dimeglumine–enhanced MR angiography and unenhanced time-of-flight MR angiography for the detection of significant peripheral arterial occlusive disease using digital subtraction angiography as our reference standard. SUBJECTS AND METHODS. Two hundred seventy-two patients underwent MR angiography and digital subtraction angiography of the iliofemoral arteries. MR angiography was performed before (2D time-of-flight acquisitions) and after (spoiled gradient-echo acquisitions) the administration of 0.1 mmol/kg of gadobenate dimeglumine at 1–2 mL/s. Contrast-enhanced MR angiography and digital subtraction angiography of the calf arte…

AdultMalemedicine.medical_specialtyContrast MediaLumen (anatomy)Arterial Occlusive DiseasesArterial Occlusive Diseases/*diagnosis Contrast Media Image Enhancement/*methods Magnetic Resonance Angiography/*methods Meglumine/*analogs & derivatives/therapeutic useSensitivity and SpecificityMegluminecontrast agents; diagnostic performance; gadobenate dimeglumine; MR angiography; peripheral arterial occlusive diseasediagnostic performancePeripheral arterial occlusive diseaseMulticenter trialOrganometallic CompoundsHumansMedicineRadiology Nuclear Medicine and imagingcontrast agentsGADOBENATE DIMEGLUMINEAgedPeripheral Vascular DiseasesMR angiographymedicine.diagnostic_testbusiness.industryVascular diseaseMr angiographyReproducibility of ResultsGeneral MedicineDigital subtraction angiographyMiddle AgedSouth Americacontrast agentImage Enhancementmedicine.diseaseEuropemedicine.anatomical_structureThighFemaleRadiologybusinessperipheral arterial occlusive diseaseMagnetic Resonance AngiographyArterygadobenate dimeglumine
researchProduct

Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization

2016

International audience; Many studies have been devoted to adapting the design of gold nanoparticles to efficiently exploit their promising capability to enhance the effects of radiotherapy. In particular, the addition of magnetic resonance imaging modality constitutes an attractive strategy for enhancing the selectivity of radiotherapy since it allows the determination of the most suited delay between the injection of nanoparticles and irradiation. This requires the functionalization of the gold core by an organic shell composed of thiolated gadolinium chelates. The risk of nephrogenic systemic fibrosis induced by the release of gadolinium ions should encourage the use of macrocyclic chelat…

BiodistributiontumorMaterials scienceGadoliniumchemistry.chemical_elementNanoparticleContext (language use)Nanotechnology02 engineering and technology[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciences[ CHIM ] Chemical Sciencesnephrogenic systemic fibrosis[CHIM]Chemical SciencesGeneral Materials ScienceChelationratbiodistributionradiotherapyrenal clearance[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistry0104 chemical scienceschemistrymri contrast agentsColloidal goldSurface modification0210 nano-technologySelectivitydihydrolipoic acidmicrobeam radiation-therapy9l gliosarcoma
researchProduct

Porphyrines et tétraazamacrocycles dérivés du DOTA : association de deux ligands pour la chélation de métaux d'intérêt en imagerie médicale multimoda…

2012

The goal of my PhD thesis was to synthesize new molecules, which give access to heterobimetallic complexes with interesting properties for multimodal imaging. In this manuscript, several main points have been studied. The first part of this work concerns the synthesis and characterization of ligands. We describe here the synthesis of five new ligands based on the association of one porphyrin and one or several cyclen derivatives. Those ligands are water-soluble. During the synthesis, we have targeted improvements to our work and developed a new synthetic pathway, which allowed us to obtain one ligand incorporating a porphyrin, a cyclen derivative and a free amine function. This function cou…

Complexes hétérobimétalliquesPorphyrinsHeterobimetallic complexesGadoliniumContrast agentsRelaxivity studiesIRM / PETPorphyrinesBODIPY[ CHIM.OTHE ] Chemical Sciences/Other[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyMultimodal imagingMRI / PETChimie “click”[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyAgents de contrasteTétraazamacrocyclesTransferts d’énergieTetraazamacrocyclesEtudes de relaxivitéDOTAImagerie multimodale[CHIM.OTHE] Chemical Sciences/OtherEnergy transfer“Click” chemistry[CHIM.OTHE]Chemical Sciences/Other[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

SAFETY OF REPEATED MDCT WITH CONTRAST COMPOUND IN CASE OF PREVIOUS MILD OR MODERATE ADVERSE REACTION: A SINGLE CENTRE RETROSPECTIVE STUDY.

2015

Aims and objectives Methods and materials Results Conclusion Personal information References

Drugs / Reactions Safety Contrast agent-intravenous CT Professional issues Contrast agentsgenetic structuresProfessional issuesDrugs / ReactionsSafetyContrast agent-intravenousContrast agentsCT
researchProduct

Lanthanide complexes as imaging agents anchored on nano-sized particles of boehmite

2011

International audience; The synthesis of boehmite nanoparticles modified with lanthanides (Eu, Tb and Gd) is described. Their synthesis, characterization and in vitro assays with HeLa cells were performed. The nuclear magnetic relaxation dispersion (NMRD) profiles of the two chelating moieties were studied. Imaging data from laser scanning confocal fluorescence microscopy and flow cytometry revealed that the nanoscaffolds were taken up by the cells, distributed throughout the cytoplasm and showed no toxicity. This platform could represent an alternative to silica-based inert matrices as imaging vehicles.

LanthanideBoehmiteGADOLINIUM(III) COMPLEXESRELAXIVITYConfocalEUROPIUMchemistry.chemical_elementNanoparticleMetal NanoparticlesAluminum Hydroxide02 engineering and technology010402 general chemistry01 natural sciencesLanthanoid Series ElementsPROBESInorganic ChemistryCoordination ComplexesMicroscopyFluorescence microscopeAluminum OxideNANOPARTICLESHumans[CHIM]Chemical SciencesParticle SizeCYCLEN COMPLEXESFluorescent DyesMicroscopy ConfocalMRI CONTRAST AGENTS021001 nanoscience & nanotechnologyFlow Cytometry0104 chemical scienceschemistryWATER-EXCHANGELUMINESCENCE0210 nano-technologyEuropiumLuminescenceEMISSIONNuclear chemistryHeLa Cells
researchProduct

Gadolinium-chelating nanogels as MR contrast agesnts specifically targeting tumor cells

2014

Development of multifunctional nanogels coordinating paramagnetic ions and displacing targeting ligands for preferential accumulation into tumors. Low molecular-weight Gd-chelates are widely used in clinical MRI for various purposes. However, these contrast agents (CAs) have several shortcomings: they rapidly extravasate from blood vessels to the interstitial space, have a short circulation times and show poor contrast at high magnetic fields. Incorporating gadolinium into flexible nanogels has the potential of increasing intravascular half-life, accumulation and retention in specific body compartments of the CA as well as increasing the MR signal, since many metal ions can be coordinated t…

Low molecular-weight Gd-chelates MR contrast agentsSettore CHIM/07 - Fondamenti Chimici Delle TecnologieSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Gadolinium-chelating nanogels as MR contrast agents specifically targeting tumor cells

2014

Aims and objectives Methods and materials Results Conclusion Personal information References

Molecular imaging Diagnostic procedure MR-Functional imaging MR Contrast agentsMolecular genomics and proteomicsgenetic structuresMolecular imagingMRDiagnostic procedureContrast agentsMR-Functional imaging
researchProduct

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy

2014

International audience; A new efficient type of gadolinium-based theranostic agent (AGuIX) has recently been developed for magnetic resonance imaging (MRI)-guided radiotherapy. These new particles consist of a polysiloxane network surrounded by a number of gadolinium chelates, usually 10. Due to their small size (<5 nm), AGuIX typically exhibit biodistributions that are almost ideal for diagnostic and therapeutic purposes. For example, while a significant proportion of these particles accumulate in tumours, the remainder is rapidly eliminated by the renal route. In addition, these particles present no evidence of toxicity, in the absence of irradiation with up to 10 times the planned dose f…

Radiation-Sensitizing Agentsmedicine.medical_treatmentGadoliniumContrast MediaGadoliniumReview Article02 engineering and technologyQUANTUM DOTSIonizing radiation[ SDV.CAN ] Life Sciences [q-bio]/CancerMicechemistry.chemical_compound0302 clinical medicineNuclear magnetic resonanceNeoplasmsIN-VIVOmedicine.diagnostic_testNEUTRON-CAPTURE THERAPYGeneral Medicine021001 nanoscience & nanotechnologyMagnetic Resonance Imaging3. Good health030220 oncology & carcinogenesis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being0210 nano-technologyMRIMaterials scienceRadiotherapy and OncologySiloxanesMOTEXAFIN GADOLINIUMchemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerSDG 3 - Good Health and Well-beingIn vivoRADIATION-THERAPYmedicineAnimalsHumansBREAST-CANCERRadiology Nuclear Medicine and imagingIrradiationbusiness.industryMagnetic resonance imagingModels TheoreticalRadiation therapychemistryMotexafin gadoliniumGOLD NANOPARTICLESNanoparticlesParticleCONTRAST AGENTSIONIZING-RADIATIONNuclear medicinebusiness
researchProduct

SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media

2020

Abstract Hypersensitivity reactions (HRs) to contrast media (CM) can be distinguished in immune-mediated (including allergic reactions) and non-immune-mediated reactions, even if clinical manifestations could be similar. Such manifestations range from mild skin eruptions to severe anaphylaxis, making it important for radiologists to know how to identify and manage them. A panel of experts from the Società Italiana di Radiologia Medica e Interventistica (SIRM) and the Società Italiana di Allergologia, Asma e Immunologia Clinica (SIAAIC) provided a consensus document on the management of patients who must undergo radiological investigations with CM. Consensus topics included: the risk stratif…

lcsh:Immunologic diseases. Allergyradiologic contrast media; hypersensitivity reactions; low-osmolar contrast agents; diagnosis; managementmedicine.medical_specialtyAllergyHypersensitivity reactionsReferralImmunologyReviewCulpritRadiologic contrast media03 medical and health sciences0302 clinical medicineDiagnosisHypersensitivity reactionmedicineImmunology and AllergyMedical historyIn patientLow-osmolar contrast agentsIntensive care medicineMolecular Biologybusiness.industryLow-osmolar contrast agentmedicine.diseaseManagement030228 respiratory systemRadiological weaponPremedicationbusinesslcsh:RC581-607AnaphylaxisDiagnosi030215 immunologyClinical and Molecular Allergy
researchProduct